CD4 and myeloid sarcoma: Similarly, the MFI of ephrin-A3 was significantly higher on CD4+ T cells (p < 0.001), CD8+ T cells (p = 0.042), Tregs (p < 0.001) and Th1 cells (p = 0.003) of patients with RR-MS compared to HC (Table 3).